baber/WOPTO huggingface dataset:
Patent DE-102012101223-C5 (DE)
Title: Vorrichtung zum Verstauen von Munitionskisten
Inventor: RACZEK MATTHIAS
IPC: F42B39/28
Filed: 2012-02-15
Granted: 2019-02-28
Abstract: Vorrichtung zum Verstauen von Munitionskisten (3, 5) mit einem Stellplatz (2) zur lagegesicherten Aufnahme einer Munitionskiste (3) eines ersten Typs, mitmindestens einem Alternativstellplatz (4) zur lagegesicherten Aufnahme einer Munitionskiste (5) eines zweiten Typs, wobei sich der Stellplatz (2) und der Alternativstellplatz (4) zumindest teilweise überdecken und wahlweise entweder der Stellplatz (2) oder der Alterativstellplatz (4) nutzbar ist,wobei der Stellplatz (2) und/oder der Alternativstellplatz (4) Anschläge (6, 7, 18, 19) zur Lagesicherung einer Munitionskiste (3, 5) aufweist, wobei die Anschläge (6, 7, 18, 19) des Stellplatzes (2) und des Alternativstellplatzes (4) stufenartig gegeneinander versetzt angeordnet sind,
Patent DK-2689-D0 (DK)
Inventor: EVANS JOHN MORRIS
IPC: A61K31/405
Filed: 1989-01-04
Abstract: A pharmaceutical product comprising a potassium channel activator antihypertensive agent and a  beta -blocker antihypertensive agent as a combined preparation for simultaneous, separate or sequential use in therapy of hypertension.
Patent DK-66090-D0 (DK)
Inventor: AMDUR SHIMON
IPC: A61L31/12
Filed: 1990-03-14
Abstract: Liquid mixtures containing natural rubber latex and aqueous dispersions of hydrophillic fumed silica useful in the manufacture of dipped latex goods characterized by improved tensile strength, wet strength, break force, puncture and tear properties are disclosed.
Patent DK-352784-D0 (DK)
Inventor: KIESSLING GERHARD
IPC: H01B3/42
Filed: 1984-07-18
Abstract: 1. Impregnation materials consisting of unsaturated polyesters and acryloyl and/or methacryloyl compounds as reactive diluents and optionally conventional additives, characterised in that they contain a) hexanediol diacrylate and/or b) butanediol diacrylate as reactive diluents and in that the viscosity of the impregnation materials is at the most 1500 mPa . s.
Patent DK-488988-D0 (DK)
Inventor: MASSARDO PIETRO
IPC: C07C275/54
Filed: 1988-09-02
Abstract: A class of particularly active insecticide compounds: N-(halobenzoyl)-N min -2-halo-4-[1,1,2-trifluoro-2-(trifluoro-methoxy)ethoxy)-ph enyl-ureas, the preparation of such compounds and their use in the fight against the infestations by insects is disclosed.
Patent HU-9201215-D0 (HU)
Title: Process for the production of geminal diphosphonic acids and of medical preparations containing them
Inventor: TOGNELLA SERGIO
IPC: A61K31/66
Filed: 1990-10-11
Abstract: PCT No. PCT/EP90/01710 Sec. 371 Date Jun. 9, 1992 Sec. 102(e) Date Jun. 9, 1992 PCT Filed Oct. 11, 1990 PCT Pub. No. WO91/05791 PCT Pub. Date May 2, 1991.Diphosphonic acids of formula (I), wherein R1 and R2 are hydrogen or C1-C4 alkyl; (A) is hydrogen, halogen, hydroxy or C1-C12 alkyl; (B) is a bond, a C1-C8 alkylene chain, a cycloalkylalkylene chain, an alkylene chain substituted by cyclohexyl or cyclopentyl groups, or an aralkyl chain, an alkyl chain containing an heteroatom (O, S or N-CH3) or an ureido residue -(CH2)nl-NHCONH-(CH2)n-with n ranging from 1 to 5, R3 is hydrogen, C1-C9 alkyl, C3-C6 cycloalkyl, benzyl, phenyl or p-methoxybenzyl; (C) is C1-C5 alkyl, phenyl or an aralkyl chain; R4 is hudrogen, C1-C5 alkyl or an amino group optionally substituted by alkyl, phenyl, benzyl, p-methoxybenzyl, acyl, amminoacidic or peptide groups; R5 and R6 are 2-haloethyl or together form a 1-aziridinyl residue, are useful as antitumor agent.
Patent HU-903266-D0 (HU)
Title: Process for producing amine-derivatives and pharmaceutical preparatives containing these compounds as active substance
Inventor: WHITE JOHN FREDERICK
IPC: A61P25/28
Filed: 1990-05-30
Abstract: The invention concerns compounds having formula: <CHEM> or a salt thereof, wherein E represents hydrogen, lower alkyl or a group Ar<1>-A<1>-; Ar and Ar<1> are the same or different aryl groups (including heteroaryl) which are optionally substituted, eg by one or more substituents commonly used in pharmaceutical chemistry; A and A<1> are the same or different alkylene groups having one or two carbon atoms linking Ar or Ar<1> to N and optionally substituted by lower alkyl and/or optionally substituted aryl, B is an alkylene group of 3 or 4 carbon atoms, which may be substituted by lower alkyl; D<1> represents halogen, CH3, CR<1>R<2>NH2, SO3H or SO2NR<6>R<7> where R<1> and R<2> are independently hydrogen or lower alkyl and R<6> and R<7> are each hydrogen, lower alkyl or aralkyl of 7 to 12 carbon atoms or R<6> and R<7> togehter with the nitrogen atom to which they are attached represent a 5 or 6 membered ring, which compounds are useful, for treating depression or cerebral insufficiency or dementias in animals.
Patent HU-907959-D0 (HU)
Title: Medical preparations
Inventor: ROESSLING GEORG
IPC: A61Q19/00
Filed: 1990-10-10
Abstract: Pharmaceutical preparations are provided comprising antiandrogenically effective substances encapsulated in liposomes. These preparations are preferably used for topical treatment of androgen-dependent diseases.
Patent NO-870441-D0 (NO)
Inventor: FRANZ HELMUT
IPC: A61K47/38
Filed: 1987-02-04
Abstract: The pharmaceutical forms are intended for topical administration and employ as vehicle for and stabiliser of the active ingredient a composition which specifically confers special stability on the active ingredient IFN alpha. The forms are essentially composed of hydroxyethylcellulose and gelatin and preferably contain highly purified IFN alpha which has been prepared by DNA recombination as active ingredient.
Patent NO-895249-D0 (NO)
Inventor: STEINDAL LEIF
IPC: F27D25/00
Filed: 1989-12-22
Abstract: The present invention relates to a refractory coating (5) composition for protecting linings (4) in furnaces, ladles or launders, runners and tapping spouts for molten metals and mineral melts. The coating (5), when coming into contact with molten metal or mineral melts, undergoes a metamorphosis making the surface (12) of the coating facing the molten metal hard and durable against high temperature, while the side (11) of the coating facing the lining (4) becomes brittle. The refractory coating composition contains in percent by weight, 50-90% of a filler material having a particle size between 0 and 10 mm, 5-30% of a silicon source with a particle size below 1 mm, 3-10% carbonaceous material having a particle size below 1 mm or a liquid carbon source, 1-15% inorganic or organic binder and 0-5% microsilica. <IMAGE>
Patent NO-922595-D0 (NO)
Inventor: PAPA ANTHONY JOSEPH
IPC: C07C69/24
Filed: 1992-07-01
Abstract: An improved esterification process for producing volatile product esters by reacting a lower linear hydrocarbyl carboxylic acid with an alcohol containing from 2 to 10 carbon atoms, in a substantially non-aqueous medium, the improvement comprising minimizing the amount of acidic sulfate contained in the product ester by employing as the esterification catalyst a long chain alkylbenzene sulfonic acid catalyst, the alkyl radical containing from 8 to 20 carbon atoms, or mixtures of such catalysts.
Patent NO-923128-D0 (NO)
Inventor: BUXTON IAN RICHARD
IPC: A61K9/52
Filed: 1992-08-11
Abstract: A controlled release composition comprising spheroid cores consisting of diltiazem or a pharmaceutically acceptable salt thereof and optionally a spheronising agent, said cores being coated with a controlled release layer. The spheronising agent when present is preferably microcrystalline cellulose. Ethylcellulose is a preferred controlled release coating. The controlled release coating preferably contains a plasticiser, a surfactant and a tack-modifier.
Patent NO-924918-D0 (NO)
Inventor: MAYSTRE FRANCOIS
IPC: G01N30/02
Filed: 1992-12-18
Abstract: An analytic separation arrangement (1) comprises a system of tubes (2 - 9) including a separation zone (6), preferably a separation column, which tubes upstream the separation zone (6) are connected with reservoirs (10, 11) for an carrier (E) and a chemical sample (S) to be seperated and analyzed, and downstream the separation zone (6) are connected with a waste container (12) for the carrier containing the sample (W) and also are connected with transporting means (13, 14)for the carrier and the sample. The tube system is associated with an optical detector (15) for monitoring changes in the absorption, in the fluorescence or in the optical activity of the carrier (E) when it is transported through the tube system and past the optical detector, which is arranged in the path of the carrier behind the separation zone (6) but in front of the waste container (12). Between the separation zone (6) and the optical detector (15) there is arranged in the path of the carrier (E) a refractive index equalizing unit (16). According to the invention prior to being transported past the optical detector (15) the carrier (E), which is comming from the separation zone (6), is directed through the refractive index equalizing unit (16), where its refractive index is preferably constantly monitored and where upon detection of changes of the refractive index of the carrier the deviation is compensated by adding to the carrier a compensating agent. <IMAGE>
Patent NO-933309-D0 (NO)
Inventor: MARCHAND ROGER
IPC: F16F15/04
Filed: 1993-09-16
Abstract: - The invention relates to a suspension device for connecting on-board equipment to the structure of a vehicle such as a rotary-wing aircraft. - Advantageously, it comprises first (5) and second (6) elements which are at least approximately shaped into plates and capable of being fixed respectively to the said structure (3) and to the said equipment (2), and suspension means (7) including damping (shock-absorbing) members (14) connected respectively to the first and second elements and capable of acting along the three reference axes of roll, pitch and yaw of the said aircraft in order to absorb the linear displacements along the said axes, and elastic suspension members (15) connected respectively to the first and second elements and capable of acting about the three reference axes in order to absorb angular deflections (excursions). <IMAGE>
Patent NO-960893-D0 (NO)
Inventor: LINDNER MICHAEL
IPC: F16B21/02
Filed: 1996-03-05
Abstract: The lower component (13) is in the form of a C-shaped rail with the lengthwise opening forming the fixture opening (15). The cross-sectional length (E) of the shaft (4) is at least slightly larger than the width of the fixture openings (14,15). The transition of the cross-sectional lengthwise edges and the wide edges of the shaft are rounded on two diagonally facing ramp parts (10). The distance (A) between the underside (11) of the head (1) and the top of the foot part is slightly less than the total thickness (D) of the components (12,13) at the connecting point.
Patent NO-972947-D0 (NO)
Inventor: DUMLER NORBERT
IPC: A46B9/02
Filed: 1997-06-23
Abstract: To obtain optimal properties of transfer for the mascara liquid, individual adaptability and a characteristic appearance in a mascara brush comprising a plurality of bristles fixed in place between at least two intertwisted wire segments, the core formed by the intertwisted wire segments being bent by approximately 180 DEG , it is provided that the core is bent to form at least one reservoir of eye-type configuration. <IMAGE>
Patent NO-975334-D0 (NO)
Inventor: BOMBARDELLI EZIO
IPC: A61K31/335
Filed: 1997-11-20
Abstract: The invention relates to methods for preventing, inhibiting, or suppressing tumors by administering to a person in need of such treatment a therapeutically effective amount of one or more flavanolignanes, such as silymarin, silybin, silidianin, silicristin, dehydrosilybin, mixtures thereof, or extracts thereof as an antiproliferative. The invention further relates to the antitumor pharmaceutical composition includes a therapeutically effective amount of the flavanolignane selected from the group of silymarin, silybin, silidianin, silicristin, dehydrosilybin, and mixtures thereof, in combination with a different antitumor agent. In another embodiment, the pharmaceutical composition includes a therapeutically effective amount of a flavanolignane selected from the group of silidianin, silicristin, and mixtures thereof, with a pharmaceutically acceptable carrier or excipient. The compositions and method may be prepared or administered with different antitumoral agents for concurrent or sequential use for treating tumors, such as those typically found in the uterus, ovary, and breast.
Patent NO-990016-D0 (NO)
Inventor: STARZEWSKI KARL-HEINZ ALEKSAND
IPC: C07F17/00
Filed: 1999-01-04
Abstract: Metallocene compounds of the formulawhereCpI and CpII are carbanions having a cyclopentadienyl-containing structure,D is a donor atom andA is an acceptor atom,where D and A are linked by a reversible coordinative bond in such a way that the donor group takes on a positive (partial) charge and the acceptor group takes on a negative (partial) charge,M represents a transition metal of transition group III, IV, V or VI of the Periodic Table of the Elements (Mendeleev),X is one anion equivalent andn is, depending on the charge of M, zero, one, two, three or four,are new and can be used as catalysts for the (co)polymerization of olefins, i-olefins, alkines and/or diolefins or for ring-opening polyaddition.A typical X-ray structure analysis is represented by formula 18a.
Patent NO-994387-D0 (NO)
Inventor: GOHWILER BENNO
IPC: F21S9/03
Filed: 1999-09-10
Abstract: A solar light device is provided which is activated at the onset of darkness, which self-charges with solar energy and is independent of any source of energy. The solar light device includes a luminescent layer of foil which is operated by solar cells or a solar cell laminate. At least one accumulator is providing for accumulating energy from the solar cells. Control system electronics regulates the charging and discharging process of the least one accumulator and controls operation of the luminescent foil. The luminescent foil serves to increase visibility and thus safety or visual attractiveness.
Patent GB-0000285-D0 (GB)
Title: The synthesis of kermesic acid from 2-chloro and from 2-bromo-5,6,8-trihydroxynapiitho-1,4-quinodes and their c-c adducts at the 7-position
IPC: C07C69/00
Filed: 2000-01-10
Abstract: (2-Chloro or 2-bromo-5,6,8-trihydroxynaphtho-1,4-quinone is synthesised in six steps from 2-hydroxy-4-methoxyacetophenone. In the chloro series, 3-chloro-2-hydroxy-5-methoxy acetophenone is methylated to give 3-chloro-2,5-dimethoxyacetophenone which then is converted to methyl 3-(3-chloro-2,5-dimethoxyphenyl)-3-oxopropionate. This compound is reacted with oxalyl chloride and the product cyclised to give methyl 6-chloro-2,5,8-trihydroxynaphtho-1,4-quinone-3-carboxylate, hydrolysis and decarboxylation of which gives 6-chloro-2,6,8-trihydroxynaptho-1,4-quinone. This does not undergo the Diels-Alder reaction due to hydrogen bonding which locks the structure in the undesired tautomeric form. By acetylation-aided tautomerism which is effected with acetic anhydride, 2-chloro-5,6-diacetoxy-8-hydroxynaphtho-1,4-quinone is derived and Diels-Alder cycloaddition with (E) and (Z)-3-methoxycarbonyl-2,4-bis(trimethylsilyloxy)-penta-1,3-dienethengivesmethyl5,6-diacetoxy-3,8-dihydroxy-1-methylanthra-9,10-quinone-2-carboxylate. Hydrolysis results in kermesic acid. Methylation is another way of aiding the desired tautomerism of 6-chloro-2,5,8-trihydroxynaphtho-1,4-quinone which gives 6-chloro-5,8-dihydroxy-2-methoxynaphtho-1,4-quinone and enables a Diels-Alder reaction to take place. Addition reactions at the 7-position of 6-chloro-2,5,8-trihydroxynaphtho-1,4-quinone proceed smoothly with   a  ,  b  -unsaturated ketones to give, for example, 6-chloro-2,5,8-trihydroxy-3-(1'-methjyl-2'-ethoxycarbonyl-3'-oxobutyl)naphtho-1,4-quinone.
Patent GB-0013669-D0 (GB)
Title: Communication method
IPC: H04L29/06
Filed: 2000-06-05
Abstract: When a user of a receiving apparatus 1 accessing a data store 2 such as the Internet moves from one location to another, the initial route set up for transmitting information to the mobile station is no longer valid. When a communication path changes, the receiving apparatus notifies the data store either of a changed gateway 3,6 through which communications with the receiving apparatus may be made, or a change in address for the apparatus. This enables information may be transmitted to the apparatus using a new route.
Patent GB-0025247-D0 (GB)
Title: Optical proximity correction
IPC: G03F1/00
Filed: 2000-10-13
Abstract: A method of carrying out optical proximity correction in the design of a reticle for exposing a photoresist of a wafer in photolithography using a lens having a focal plane, the method includes generating a dense-isolated offset focus/exposure matrix, containing dense-isolated offset values, being the difference between values of linewidth for dense and isolated lines, as a function of focal plane position, for each of a plurality of different exposures; selecting from among the contours of the dense-isolated offset focus/exposure matrix for each different exposure, the flattest contour, and carrying out optical proximity correction on the basis that the exposure will be the exposure corresponding to said flattest contour. <IMAGE>
Patent GB-0107999-D0 (GB)
Title: Lifting and lowering apparatus
IPC: A61G7/012
Filed: 2001-03-30
Abstract: Apparatus for lifting or/and lowering persons has two interconnected X-frames each with two pivotally connected members arranged in an upright position in spaced parallel relationship, a support supported by the members, and one of two inflatable bags surrounding the pivotal connections so that portions of the bags lie between members, whereby inflation and deflation of the bags, opens the X-frames in scissors-fashion and allows the frames to close in a similar fashion thereby raising and lowering the support.
Patent GB-0109778-D0 (GB)
Title: Magnetically suspended fluid pump and control system
IPC: A61M60/822
Filed: 2000-02-02
Abstract: A blood pump 51 for assisting a heart is provided by a stator and a rotor. The rotor is rotated relative to the stator by a motor. The blood pump apparatus includes a flow rate controller 92 and a flow rate sensor 91 to avoid excessively low or reverse flow through the pump when a pulsatile flow rate is provided. The flow rate controller may include a heart caliper 400/500 for measuring the dimension of a heart ventricle to control the flow rate to avoid overly distending or contracting the ventricle. The caliper 400/500 comprises two caliper arms positioned at opposing sides of the ventricle. Measurement of the ventricle dimension may be achieved by an angular measurement device measuring changes in the angle between the arms (fig 9) or by a pair of ultrasonic transducers located at opposite sides of the ventricle (504, 505, figs 10a and 10b). The motor for the pump may comprise a magnetic drive comprising a permanent magnet (31 fig 1a) armature windings (32, fig 1a) and back-iron (33, fig 1a). The rotor may be suspended in the stator by a magnetic suspension comprising two permanent magnet arrays (11, 12 fig 1a). The rotor may be axially supported by a Lorentz-force bearing (13-18, fig 1a). The pump may also include an axial position actuator engaged with the stator or rotor to permit the axial alignment between the stator and rotor to be adjusted.
Patent GB-0216414-D0 (GB)
Title: Organic compounds
IPC: A61K39/00
Filed: 2002-07-15
Abstract: The hsp70 gene from an Arthrobacter species has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
Patent GB-0224267-D0 (GB)
Title: Sensors
IPC: G01N27/407
Filed: 2002-10-18
Abstract: In a zirconia oxygen sensor utilising a diffusion hole, the hole is made by inserting an organic fibre or element in the green ceramic and firing to destroy the fibre or element and leave a hole in its place. A package for a sensor is described in which the wire/posts for the electrical connections also form a cage to hold the sensor, heater(s) and thermal insulation firmly and plug into an electrical socket.
Patent GB-0321423-D0 (GB)
Title: Method and apparatus for providing a multimedia service
IPC: H04L12/56
Filed: 2003-09-12
Abstract: A method of providing a combinational communication service to a user of a communication network where a physical channel is defined for the user in respect of a circuit switched connection primarily for carrying real time data, the method comprising interrupting the transmission of real time data on said physical channel in order to allow non-real time data to be transmitted on the physical channel or to allow signalling, for setting up a packet switched bearer for carrying non-real time data, to be transmitted on the physical channel.
Patent GB-0427392-D0 (GB)
Title: Stabilised 99mTc compositions
IPC: A61K51/04
Filed: 2004-12-15
Abstract: The present invention relates to stabilised 99mTc radiopharmaceutical compositions of the ligand tetrofosmin, which include an ascorbic acid or ascorbate radioprotectant, in the absence of an antimicrobial preservative. The invention also provides lyophilised kits suitable for the bulk preparation of multiple unit patient doses of 99mTc-tetrofosmin metal complexes. Also disclosed are unit doses of 99mTc-tetrofosmin, together with processes for preparing such unit doses from the lyophilised bulk vial.
Patent GB-0503718-D0 (GB)
Title: Roof vent
IPC: E05F15/12
Filed: 2005-02-23
Abstract: The present invention relates to roof vents and particularly roof vents which can be slid relative to the roof on which they are mounted. The roof vent has a simple mechanism, and is sealable to prevent the ingress of water through the roof vent.
Patent GB-0517175-D0 (GB)
Title: Compounds
Filed: 2005-08-22
Abstract: The present invention relates to novel compounds of formula (IA) or a salt thereof: wherein: A is attached to the phenyl group at the meta position or the para position relative to the cyclopropyl group, and is selected from the group consisting of: —SO2NR5—, —SO2CR2R3—, —CR2R3SO2— and —NR5SO2—; R1 is hydrogen, C1-6alkyl, haloC1-6alkyl or C2-6alkylene; R2 and R3 are independently hydrogen or C1-6alkyl; R4 is hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-6alkoxy or haloC1-6alkoxy; R5 is hydrogen, C1-6alkyl, or a phenyl optionally substituted by R4; and R6 is hydrogen, C1-6alkyl, haloC1-6alkyl, C1-6alkoxy or haloC1-6alkoxy; processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as modulators of dopamine D3 receptors, e.g. to treat substance related disorders, as antipsychotic agents premature ejaculation or cognition impairment.
Patent GB-0520845-D0 (GB)
Title: Salt enhancing compounds and use
IPC: A23L23/10
Filed: 2005-10-14
Abstract: Use as a salt enhancer and flavour of S- or O-carboxyalkylated amino acids and peptide compounds of formula I and consumables or flavour compositions comprising such compounds. Method of flavouring consumables, in particular of replacing sodium from said consumables by employing said compounds while using a reduced salt content, or enhancing the salty taste of salt at a given salt concentration. Novel compounds of formula I.
Patent GB-0610240-D0 (GB)
Title: Dispersions of nano-sized materials
Filed: 2006-05-23
Abstract: Nano-sized particles of inorganic material, e.g. zinc oxide, cerium oxide or titanium oxide, can be dispersed to form a stable dispersion in a liquid medium, by using as the dispersant a compound of formula (I): in which: R1 represents a hydrogen atom or a lower alkyl group; R2 represents a carboxy group, or a salified or esterified carboxy group; m is 1 or 2; and n is a number from 4 to 200.